2025-10-08T11:14:24-05:00 2024-12-31 410746749 CLIFTONLARSONALLEN LLP 220 S 6TH STREET SUITE 300 MINNEAPOLIS MN 55402 990 2024-01-01 411426406 MINNEAPOLIS HEART INSTITUTE FOUNDATION MINN 6128633833 920 E 28TH STREET 100 MINNEAPOLIS MN 554071191 CHARLES ZAUGG CHIEF FINANCIAL OFFICER 6128633833 2025-10-06 1 0 ANN NEIL P01817922 6123764500 2025-10-06 2024 2025-03-06 01:10:19Z CHARLES ZAUGG 920 E 28TH STREET 100 MINNEAPOLIS MN 554071191 27695433 0 X WWW.MPLSHEART.ORG X 1982 MN TO IMPROVE THE CARDIOVASCULAR HEALTH OF INDIVIDUALS AND COMMUNITIES THROUGH RESEARCH & EDUCATION. 32 32 143 1762 0 0 7376505 16210682 5033714 6588288 2334828 1355537 -408580 -512559 14336467 23641948 95308 1294745 0 0 11179969 12032640 0 0 2455397 5274878 6137086 16550155 19464471 -2213688 4177477 66731497 74457179 10396446 10608958 56335051 63848221 X THE MISSION OF THE MINNEAPOLIS HEART INSTITUTE FOUNDATION IS TO IMPROVE THE CARDIOVASCULAR HEALTH OF INDIVIDUALS AND COMMUNITIES THROUGH INNOVATIVE RESEARCH AND EDUCATION. 0 0 12388264 1294745 6398984 2024 MHIF RESEARCH ACCOMPLISHMENTSI.MHIF REACHED AN IMPORTANT RESEARCH MILESTONE WITH U.S. FDA APPROVAL OF THE TRICLIP (ABBOTT), A NON-SURGICAL, TRANSCATHETER EDGE-TO-EDGE REPAIR SYSTEM. MHIF WAS THE TOP ENROLLER - ENROLLING THE FIRST AND LARGEST NUMBER OF PATIENTS OF ALL 68 CLINICAL SITES PARTICIPATING IN THE TRILUMINATE PIVOTAL TRIAL IN THE U.S., CANADA AND EUROPE, LED BY PAUL SORAJJA, MD, THE ROGER L. AND LYNN C. HEADRICK FAMILY CHAIR OF THE MHIF VALVE SCIENCE CENTER AND GLOBAL PRINCIPAL INVESTIGATOR FOR THE PIVOTAL TRIAL. THE MHIF IMAGING CORE LAB, LED BY JOAO CAVALCANTE, MD, DIRECTOR OF THE MHIF CARDIOVASCULAR IMAGING RESEARCH CENTER, PROVIDED ADVANCED CARDIAC IMAGING ANALYSIS FOR THE PIVOTAL TRIAL. II.MHIF INITIATED FIRST ENROLLMENTS IN THE PRECISE PROCEDURAL AND PCI PLAN (P4) RESEARCH TRIAL EVALUATING THE POTENTIAL FOR ADVANCED CARDIOVASCULAR IMAGING TO ENHANCE PATIENT CARE. PATIENTS RECEIVE CT IMAGING WITH STATE-OF-THE-ART 3D MODELING PROVIDED BY THE TRIAL AS PART OF PRE-PROCEDURE PLANNING TO GUIDE THE PCI USED TO OPEN A BLOCKAGE IN THE HEART. THE P4 RESEARCH TRIAL IS A GLOBAL, MULTICENTER, RANDOMIZED TRIAL SPONSORED BY COREAALST BV TO COMPARE NOVEL CORONARY CT-GUIDED PCI AND STANDARD IVUS-GUIDED PCI. THE FIRST U.S. PROCEDURE FOR THE P4 TRIAL WAS PERFORMED BY DRS. YADER SANDOVAL & EMMANOUIL BRILAKIS, IN COLLABORATION WITH DRS. JOHN LESSER AND JOAO CAVALCANTE, ALL STUDY INVESTIGATORS AT MHIF. III.MHIF EXPERTISE BRINGS LEADERSHIP OPPORTUNITIES ACROSS RESEARCH, INCLUDING FIRST-IN-WORLD OPPORTUNITIES WITH NEW TECHNOLOGIES: MHIF PRINCIPAL INVESTIGATOR DR. JOHN ZAKAIB WAS AMONG THE FIRST TO ENROLL PATIENTS AND REMAINS THE TOP ENROLLER IN THE LEADR CLINICAL STUDY EVALUATING NOVEL CONDUCTION SYSTEM PACING WITH INVESTIGATIONAL OMNIASECURE DEFIBRILLATION LEAD (MEDTRONIC). MHIF TEAM WITH DRS. PAUL SORAJJA, VINAYAK BAPAT AND NADIRA HAMID ENROLLED THE FIRST PATIENT IN THE U.S. VISTA EARLY FEASIBILITY STUDY FOR A NEW TRANSCATHETER TRICUSPID VALVE TECHNOLOGY (VDYNE). MHIF PRINCIPAL INVESTIGATOR DR. JAY TRAVERSE ENROLLED THE FIRST PATIENT IN THE SUPER-SATURATED OXYGEN COMPREHENSIVE OBSERVATIONAL REGISTRY TO PROVIDE EFFICACY EVIDENCE FOR SSO2 THERAPY (ZOLL) TO REDUCE HEART FAILURE AND MORTALITY AFTER LEFT ANTERIOR DESCENDING ST-ELEVATION MYOCARDIAL INFARCTION (LAD STEMI) HEART ATTACKS. IV.MHIF WAS RECOGNIZED AS ONE OF THE 2024 CRF SCIENTIFIC EXCELLENCE TOP 10 (SET-10) FOR OUTSTANDING RESEARCH AND GROUNDBREAKING CONTRIBUTIONS TO INTERVENTIONAL CARDIOVASCULAR MEDICINE, PRESENTED AT TCT 2024. THIS PRESTIGIOUS RECOGNITION REFLECTS THE RELENTLESS DEDICATION, INNOVATION, AND HARD WORK OF MHIF PHYSICIANS AND SCIENTISTS, WHOSE RESEARCH EXEMPLIFIES THE SIGNIFICANT ADVANCEMENTS THEY ARE DRIVING IN THE FIELD OF CARDIOVASCULAR MEDICINE.V.2024 STATS:- 350+ NEW PATIENTS ENROLLED IN RESEARCH; 220+ ACTIVE STUDIES WITH 2200+ PATIENTS AT ANY GIVEN TIME- 3,000+ VISITS WITH PATIENTS WHO HAVE HOPE AND OPTIONS THROUGH RESEARCH - 270 PUBLICATIONS IN LEADING, PEER-REVIEWED JOURNALS (A COMPLETE LISTING OF MHIF PUBLICATIONS IN 2024 IS AVAILABLE AT MPLSHEART.ORG/2024PUBLICATIONS - 90+ POSTERS AND ABSTRACTS ACCEPTED TO NATIONAL AND INTERNATIONAL CONFERENCES - 245 PODIUM PRESENTATIONS AND INVITED TALKS - 15 MEDIA PRESENTATIONS - 90,000+ DOWNLOADS FROM PHYSICIANS AROUND THE WORLD FOR THE SUITE OF MHIF DIGITAL APPLICATIONS AVAILABLE SHARING EXPERTISE AND CLINICAL INSIGHTS IN HEART VALVE AND CORONARY ARTERY DISEASE - 8 MHIF INTERNATIONAL SCHOLARS CONTRIBUTED TO ADVANCING RESEARCH; THESE SCHOLARS ARE PRACTICING MEDICAL DOCTORS FROM AROUND THE WORLD WHO COME TO MHIF TO PARTICIPATE IN RESEARCH IN PARTNERSHIP WITH LEADING MHIF RESEARCH PHYSICIANS - 11,000+ HOURS OF PROFESSIONAL AND COMMUNITY EDUCATION EACH YEAR REACHING 4,000+ ATTENDEES - 5,500+ MEMBERS OF THE COMMUNITY CELEBRATED THE IMPACT OF LIFESAVING RESEARCH AT MHIF'S HEART360 CONCERT FOR WORLD-CLASS HEART RESEARCH WITH BRAD PAISLEY AT THE ARMORY IN MINNEAPOLIS. 695142 0 189304 2024 MHIF EDUCATION HIGHLIGHTSEQUAL TO OUR COMMITMENT TO RESEARCH IS OUR DEDICATION TO SHARING THE LEARNINGS FROM RESEARCH THROUGH EDUCATION, ALLOWING FOR LOCAL, NATIONAL AND INTERNATIONAL IMPACT AS WE CHALLENGE AND ADVANCE THE STANDARD OF CARE FOR ALL PATIENTS. MHIF PROUDLY SHARED THE DETAILS OF OUR RESEARCH THROUGH 600+ PUBLICATIONS, PRESENTATIONS AND ABSTRACTS AT NATIONAL AND INTERNATIONAL CONFERENCES. WE PUBLISHED 270 MANUSCRIPTS IN PEER-REVIEWED JOURNALS, SHARING LEARNINGS FROM WORLD-CLASS CARDIOVASCULAR RESEARCH. WE ALSO OFFERED VARIOUS PUBLIC AND PROFESSIONAL EVENTS (MANY OF WHICH WERE STILL VIRTUAL) TO INCREASE AWARENESS, UNDERSTANDING AND MANAGEMENT OF VARIOUS HEART CONDITIONS. MANY OF OUR EVENTS ATTRACTED PARTICIPANTS FROM AROUND THE WORLD.OUR CARDIOVASCULAR GRAND ROUNDS PROGRAM ENSURES ATTENDEES ARE WELL-VERSED IN THE LATEST RESEARCH OUTCOMES AND EVIDENCE-BASED GUIDELINES. THROUGH 32 SESSIONS FEATURING 46 SPEAKERS, MHIF PROVIDED PROFESSIONAL EDUCATION TO MORE THAN 3,200 HEALTH CARE PROFESSIONALS. THESE ACCREDITED EDUCATION ACTIVITIES PROVIDE PHYSICIANS AND OTHER HEALTH CARE PROVIDERS THE OPPORTUNITY TO REVIEW AND DISCUSS THE LATEST DEVELOPMENTS IN CARDIOVASCULAR CARE EVERY MONDAY MORNING DURING OUR GRAND ROUNDS SEASON (SEPTEMBER-MAY).IN 2024, MHIF HOSTED 10 INTERNS FROM AROUND THE COUNTRY WHO CONTRIBUTED TO 10 GROUNDBREAKING RESEARCH PROJECTS. THANKS TO THE GENEROUS SUPPORT FROM INDIVIDUAL DONORS, MHIF OFFERS AN EXCEPTIONAL CLINICAL RESEARCH INTERNSHIP PROGRAM TAILORED FOR UNDERGRADUATE STUDENTS ASPIRING TO A CAREER IN MEDICINE OR PURSUING A PRE-MED TRACK. THIS DISTINCTIVE LEARNING OPPORTUNITY INVOLVES MATCHING INTERNS WITH PHYSICIAN MENTORS WHO OVERSEE INVESTIGATOR-INITIATED RESEARCH PROJECTS. OTHER ASPECTS OF THE INTERNSHIP INCLUDE SHADOWING HOSPITAL ROTATIONS, ATTENDING INSIGHTFUL FIELD TRIPS, ENGAGING IN LUNCH-AND-LEARN SESSIONS WITH ALLINA HEALTH MINNEAPOLIS HEART INSTITUTE PHYSICIANS, PRESENTING THEIR RESEARCH FINDINGS AT AN OPEN-HOUSE, POSTER SESSION. NUMEROUS RESEARCH ENDEAVORS CULMINATE IN INTERNS POTENTIALLY CO-AUTHORING ARTICLES PUBLISHED IN RENOWNED SCIENTIFIC JOURNALS. ADDITIONALLY, SELECT INTERNS MAY HAVE THE CHANCE TO SHOWCASE THEIR WORK AT NATIONAL CARDIOVASCULAR CONFERENCES.SINCE THE INCEPTION OF THE INTERNSHIP PROGRAM, 244 CLINICAL RESEARCH INTERNS HAVE CONTRIBUTED TO 223 POSTERS AND PRESENTATIONS AT NATIONAL SCIENTIFIC SESSIONS, 219 PUBLICATIONS IN PEER-REVIEWED JOURNALS, AND 95% OF FORMER INTERNS ARE PRACTICING PHYSICIANS, IN MEDICAL SCHOOL OR IN A HEALTHCARE RELATED FIELD (59% ARE PRACTICING PHYSICIANS!). 13083406 1 1 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 56 0 1 143 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 32 32 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AR FL GA HI IL KS KY MD MA MI MN MS NH NJ NM NY NC ND OR PA RI SC TN UT VA WV WI DC X X X CHARLES ZAUGG 6128633833 920 E 28TH STREET MINNEAPOLIS MN 55407 THOMAS GUNDERSON CHAIR 10.00 X X 0 0 0 JEFFREY STEINLE PAST CHAIR 2.00 X X 0 0 0 GREG GRAVES VICE CHAIR 2.00 X X 0 0 0 CARMEN VOLKART TREASURER 1.50 X X 0 0 0 LORI MILBRANDT SECRETARY 10.00 X X 0 0 0 BEN BACHE-WIIG MD DIRECTOR 1.00 X 0 0 0 MOSI BENNETT MD DIRECTOR 0.50 X 0 0 0 CONLEY BROOKS JR DIRECTOR 1.00 X 0 0 0 SHARON HAWKINS DIRECTOR 0.25 X 0 0 0 DAVID HURRELL MD DIRECTOR 2.00 X 0 0 0 WILLIAM KATSIYIANNIS MD DIRECTOR 1.00 X 0 0 0 JIM KING DIRECTOR 2.50 X 0 0 0 GINNY KIRBY DIRECTOR 1.50 X 0 0 0 PATRICE KLOSS DIRECTOR 2.00 X 0 0 0 RICHARD MEYER DIRECTOR 3.00 X 0 0 0 MARC NEWELL MD DIRECTOR 5.00 X 0 0 0 MICHAEL PETERSON MD DIRECTOR 1.00 X 0 0 0 RETU SAXENA MD DIRECTOR 1.00 X 0 0 0 SCOTT SHARKEY MD DIRECTOR 12.00 X 0 0 0 JAY TRAVERSE MD DIRECTOR 1.00 X 0 0 0 ARIEL JOHNSON PHD DIRECTOR 0.50 X 0 0 0 BOBBY STEFFEN MD DIRECTOR 1.00 X 0 0 0 BREE WILLIAMSON DIRECTOR 1.00 X 0 0 0 FRANCES HOFFMAN DIRECTOR 1.00 X 0 0 0 JOSH HOWELL DIRECTOR 2.00 X 0 0 0 KEVIN HARRIS MD DIRECTOR 4.00 X 0 0 0 KRISTIN BOWLDS DIRECTOR 2.00 X 0 0 0 STEVEN BRADLEY DIRECTOR 2.50 X 0 0 0 MICHAEL CUMMINGS MD DIRECTOR 1.00 X 0 0 0 JOHN MACK DIRECTOR 2.00 X 0 0 0 ALLISON O'CONNOR DIRECTOR 2.00 X 0 0 0 TIM THORPE DIRECTOR 2.00 X 0 0 0 DOMINICA TALLARICO DIRECTOR 1.00 X 0 0 0 JOSEPH SCHWARTZ DIRECTOR 1.00 X 0 0 0 KRISTINE FORTMAN CHIEF EXECUTIVE OFFICER 50.00 X 460662 0 163657 CHARLES ZAUGG CHIEF FINANCIAL OFFICER 40.00 X 206389 0 58217 ROSS GARBERICH VICE PRESIDENT - SCIENTIFIC SERVICES 40.00 X 193538 0 80225 LISA TINDELL VICE PRESIDENT - RESEARCH 40.00 X 203501 0 57782 JESSE HICKS VICE PRESIDENT-ADVANCEMENT 40.00 X 237718 0 76351 KRISTIN LAMBRECHT PROGRAM DIRECTOR - CIRC 40.00 X 164541 0 44845 BAVANA RANGAN PROGRAM DIRECTOR - CCAD 40.00 X 183887 0 30504 LARISSA STANBERRY DIRECTOR OF DATA SCIENCE 40.00 X 184804 0 32168 CINDY RESMAN VICE PRESIDENT - MARKETING & COMMUNICATIONS 40.00 X 197072 0 78743 NANCY WILSON DIRECTOR OF ADVANCEMENT 40.00 X 165227 0 55377 2197339 0 677869 27 0 1 0 ATMOSPHERE COMMERCIAL INTERIORS 81 SOUTH 9TH STREET SUITE 450 MINNEAPOLIS MN 55402 OFFICE REMODELING 270246 CLIFTONLARSONALLEN 220 SOUTH 6TH STREET SUITE 300 MINNEAPOLIS MN 55402 AUDIT AND TAX SERVICES 100405 2 9582 615869 15585231 1637704 16210682 RESEARCH STUDY REVENUE 541900 5423076 5423076 SERVICE INCOME 541900 1165212 1165212 6588288 1200821 1200821 3206113 3051397 154716 154716 154716 489529 615869 1002088 -512559 -512559 23641948 6588288 0 842978 X 1294745 1294745 1494367 459180 718282 316905 8567439 6130979 1339671 1096789 530025 375330 83752 70943 732540 512632 121642 98266 708269 490673 120657 96939 85474 43057 34882 7535 70093 70093 88902 88902 2434580 1929530 435499 69551 277053 2122 7670 267261 277663 146820 10190 120653 493015 46168 443167 3680 1015099 762973 147414 104712 575407 365975 116359 93073 328970 262043 34937 31990 153739 95287 58452 MISCELLANEOUS AND BAD D 230794 101681 61966 67147 EMPLOYEE DUES AND MEMBE 42699 13542 26010 3147 EMPLOYEE SEMINAR FEES 34794 30416 1599 2779 EQUIPMENT/MAINTENANCE 23484 18862 2396 2226 5320 1391 2128 1801 19464471 13083406 3925668 2455397 1759101 2096382 11641047 15631155 8284600 6699334 2231638 3036917 342669 348520 4320495 1948883 1785468 2371612 30764995 34768601 1779589 1949709 8142390 7554949 66731497 74457179 2214429 2943361 87661 90760 8094356 7574837 10396446 10608958 X 12695578 13587954 43639473 50260267 56335051 63848221 66731497 74457179 4177477 3335693 0 X X 0 1 X 1 0 X ABBOTT NORTHWESTERN HOSPITAL MINNEAPOLIS MN 13732545 10729875 17801434 7376504 16210682 65851040 13732545 10729875 17801434 7376504 16210682 65851040 16753521 49097519 655272 941514 838820 1377795 1200821 5014222 70865262 27340169 0.69280 0.68190 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 25939165 185717 3075825 981807 28218900 24265464 182792 2393916 903007 25939165 23720058 4811688 -3433065 833217 24265464 21900155 21827 2568161 770085 23720058 19894833 20000 2720319 734998 21900155 0.00000 0.64961 0.35039 0 0 2500132 890475 1609657 1820363 1058408 761955 2371612 RIGHT OF USE ASSET, NET 7268768 PRINCIPAL 457 (F) 286181 7554949 LEASE LIABILITY 7574837 7574837 X 26888739 3335693 3335693 23553046 88902 88902 23641948 19375569 0 19375569 88902 88902 19464471 PART V, LINE 4: THE FOUNDATION'S ENDOWMENT FUNDS ARE USED FOR EDUCATION, CARDIOLOGY RESEARCH, CARDIAC SURGERY RESEARCH AND TO SUPPORT RESEARCH CHAIRS AND PHYSICIAN RESEARCH. PART X, LINE 2: THE FOUNDATION HAS RECEIVED A DETERMINATION LETTER FROM THE INTERNAL REVENUE SERVICE INDICATING IT IS CLASSIFIED AS A TAX-EXEMPT ORGANIZATION UNDER SECTION 501(C)(3) AND IS NOT A PRIVATE FOUNDATION UNDER SECTIONS 509(A)(1) AND 170(B)(1)(A)(III) OF THE INTERNAL REVENUE CODE. THE FOUNDATION IS ALSO EXEMPT FROM MINNESOTA INCOME TAXES UNDER MINNESOTA STATUTE CHAPTER 290.05. THE FOUNDATION IS SUBJECT TO FEDERAL AND STATE INCOME TAXES ONLY ON ANY UNRELATED BUSINESS INCOME UNDER THE PROVISIONS OF SECTION 511 OF THE INTERNAL REVENUE CODE. THE FOUNDATION FOLLOWS ACCOUNTING STANDARDS FOR UNCERTAIN TAX POSITIONS AND FILES AS A TAX-EXEMPT ORGANIZATION. THE FOUNDATION HAS NO UNCERTAIN INCOME TAX POSITIONS AND NO LIABILITY HAS BEEN RECOGNIZED BY THE FOUNDATION UNDER THIS STANDARD. HEART 360 1048975 577887 471088 76735 163376 420000 300634 HOPE HEALTH AND HUMOR 44922 30078 14844 5000 32540 3400 1 11501 7904 3597 403 1105398 615869 489529 81735 196319 420000 304034 1002088 -512559 0 AMERICAN HEART ASSOCIATION 7272 GREENVILLE AVENUE DALLAS TX 75231 135613797 501(C)(3) 10000 0 N/A N/A TABLE SPONSORSHIP AT GALA GLOBAL HEARTCARE FOUNDATION 8647 E ARTISAN PASS SCOTTSDALE AZ 85266 922653485 501(C)(3) 1276245 0 N/A N/A TRANSFER OF DONOR FUNDS PER DONOR REQUEST. 2 0 1 X X X X 0 1 0 0 0 0 0 0 0 KRISTINE FORTMAN CHIEF EXECUTIVE OFFICER 394164 0 66240 0 258 0 163657 0 0 0 624319 0 66240 0 JESSE HICKS VICE PRESIDENT-ADVANCEMENT 216828 0 20800 0 90 0 76351 0 0 0 314069 0 20800 0 CINDY RESMAN VICE PRESIDENT - MARKETING & COMMUNI 185034 0 11900 0 138 0 43069 0 35674 0 275815 0 11900 0 ROSS GARBERICH VICE PRESIDENT - SCIENTIFIC SERVICES 181019 0 12459 0 60 0 66687 0 13538 0 273763 0 12459 0 CHARLES ZAUGG CHIEF FINANCIAL OFFICER 192914 0 13217 0 258 0 45219 0 12998 0 264606 0 13217 0 LISA TINDELL VICE PRESIDENT - RESEARCH 185459 0 17784 0 258 0 57782 0 0 0 261283 0 17784 0 NANCY WILSON DIRECTOR OF ADVANCEMENT 136072 0 28926 0 229 0 28421 0 26956 0 220604 0 28926 0 LARISSA STANBERRY DIRECTOR OF DATA SCIENCE 173018 0 11648 0 138 0 31197 0 971 0 216972 0 11648 0 BAVANA RANGAN PROGRAM DIRECTOR - CCAD 167676 0 16151 0 60 0 30504 0 0 0 214391 0 16151 0 KRISTIN LAMBRECHT PROGRAM DIRECTOR - CIRC 138186 0 26265 0 90 0 31793 0 13052 0 209386 0 26265 0 PART I, LINE 4B PARTICIPANTS IN A 457(F) PLAN INCLUDE THE FOLLOWING INDIVIDUALS: KRISTINE FORTMAN, CHARLES ZAUGG, TAMARA O'BLACK, JESSE HICKS, ROSS GARBERICH, LISA TINDELL, JANET DICK, CINDY RESMAN, AND KAREN PHANG. TOTAL AMOUNTS CONTRIBUTED TO THE PLAN IN 2024 WERE AS FOLLOWS: KRISTINE FORTMAN: $39,366 CHARLES ZAUGG: $9,818 JESSE HICKS: $10,816 ROSS GARBERICH: $9,256 LISA TINDELL: $9,248 KAREN PHANG: $18,200 CINDY RESMAN: $9,138 NO FUNDS WERE DISTRIBUTED FROM THE 457(F) PLAN IN 2024. X 16 1637704 MARKET VALUE 0 0 1 0 PART I, COLUMN (B): COLUMN (B) REPORTS THE NUMBER OF ITEMS CONTRIBUTED. FORM 990, PART VI, SECTION A, LINE 1A THE FOUNDATION'S EXECUTIVE COMMITTEE CONSISTS OF THE BOARD OFFICERS, CHAIRS OF EACH COMMITTEE OF THE BOARD AND ANY OTHER SUCH MEMBERS AS DIRECTED BY THE CHAIR. THE CHAIR OF THE BOARD SHALL BE THE CHAIR OF THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE HAS ALL THE POWERS OF THE BOARD BETWEEN MEETINGS OF THE BOARD, EXCEPT THAT IT SHALL NOT HAVE THE POWER TO FILL VACANCIES OF ITS OWN MEMBERSHIP NOR VACANCIES IN THE MEMBERSHIP OF THE BOARD OF DIRECTORS, THE POWER TO FILL SUCH VACANCIES BEING VESTED IN THE BOARD. IN ADDITION, UNLESS OTHERWISE DIRECTED BY THE BOARD, THE EXECUTIVE COMMITTEE SHALL FUNCTION AS THE PERSONNEL, FINANCE AND AUDIT COMMITTEES. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM. THE FORM 990 IS REVIEWED BY THE FINANCE AND AUDIT COMMITTEE WHO THEN PASSES IT ALONG TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS FOR REVIEW AND APPROVAL. THE FORM 990 IS PROVIDED TO THE BOARD OF DIRECTORS IN ADVANCE OF THE EXECUTIVE MEETING WHERE ACTION IS TAKEN TO APPROVE OR MODIFY THE FORM 990. UPON APPROVAL, THE FORM 990 IS FILED WITH GOVERNMENT AGENCIES. FORM 990, PART VI, SECTION B, LINE 12C ALL BOARD MEMBERS, PHYSICIANS, AND RESEARCH STAFF ARE COVERED BY A CONFLICT OF INTEREST POLICY REQUIRING ANNUAL CONFLICT OF INTEREST DISCLOSURES, AND MAY BE SUBJECT TO CONFLICT MANAGEMENT PLANS (CMPS) AS DETERMINED BY THE APPROPRIATE COI COMMITTEE OR DEPARTMENT. COI DISCLOSURES AND CMPS ARE DOCUMENTED AND HELD CONFIDENTIALLY. IN THE CASE OF BOARD MEMBERS, CMPS MAY INCLUDE EXCLUSION FROM THE PORTION OF ANY MEETING DURING WHICH PROPOSED TRANSACTIONS OR ARRANGEMENTS WITH THE FOUNDATION THAT RAISE ACTUAL OR POTENTIAL CONFLICTS OF INTEREST ARE DISCUSSED. FORM 990, PART VI, SECTION B, LINE 15 A SUBCOMMITTEE OF THE EXECUTIVE COMMITTEE SERVES AS THE COMPENSATION COMMITTEE FOR THE CEO. EXECUTIVE COMMITTEE OBTAINS COMPARABLE COMPENSATION DATA FROM SURVEYS AND/OR CONSULTANTS TO ASSIST THEM IN THEIR DELIBERATIONS. ALL MEMBERS OF THE EXECUTIVE COMMITTEE ARE INDEPENDENT OF THE CEO AND EXECUTIVE TEAM. THE DELIBERATION AND DECISION PROCESS IS CONTEMPORANEOUSLY SUBSTANTIATED IN THE EXECUTIVE COMMITTEE MEETING MINUTES. COMPENSATION PACKAGES FOR THE EXECUTIVE TEAM WERE DETERMINED THROUGH A COMBINATION OF PERFORMANCE REVIEWS, COMPARABILITY DATA FROM AN OUTSIDE CONSULTANT, AND THROUGH DISCUSSIONS WITH THE VP OF HUMAN RESOURCES, THE CEO, AND BOARD CHAIR. THE PROCESS DESCRIBED HERE WAS LAST COMPLETED IN 2024. FORM 990, PART VI, SECTION C, LINE 19 THE FOUNDATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE AT THE FOUNDATION'S OFFICES. IF REQUESTED, COPIES ARE AVAILABLE BY MAIL. THE AUDITED FINANCIAL STATEMENTS AND ANNUAL REPORT ARE AVAILABLE ON THE FOUNDATION'S WEBSITE. THE FORM 990 AND ALL ACCOMPANYING SCHEDULES ARE AVAILABLE ON-LINE THROUGH GUIDESTAR OR UPON REQUEST. FORM 990, PART IX, LINE 11G RESEARCH STUDY - IRB FEES: PROGRAM SERVICE EXPENSES 149,452. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 149,452. MEDICAL CONSULTING/TESTING FEES: PROGRAM SERVICE EXPENSES 665,237. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 665,237. OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 1,114,841. MANAGEMENT AND GENERAL EXPENSES 279,034. FUNDRAISING EXPENSES 63,451. TOTAL EXPENSES 1,457,326. MARKETING CONSULTING: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 69,705. FUNDRAISING EXPENSES 6,100. TOTAL EXPENSES 75,805. TEMPORARY STAFFING: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 86,760. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 86,760. FORM 990, PART XII, LINE 2C: THIS PROCESS HAS NOT CHANGED FROM PRIOR YEAR.